Open Research and Contributor Identifier

ORCID - 0000-0002-6770-8762

Department

Applied Health Science

Education

• The University of Texas at Austin, Ph.D. (Clinical Psychology), 2014

• Indiana University School of Medicine, APA-Accredited Pre-Doctoral Clinical Psychology Internship, 2013-2014

• The University of Texas at Austin, M.A., 2011

• Swarthmore College, B.A., 2005

Background

Selected Grants/Awards

• 2023-2026: Principal Investigator, Assessing real-world evidence of the effects of opioid analgesic tapering on substance-related problems (NIH/NIDA Grant #R01DA059026) 
• 2021: Trustees Teaching Award, Indiana University School of Public Health-Bloomington 
• 2021-2024: Principal Investigator, A population-based, genetically informed study of the effects of chronic pain on suicidal behavior (American Foundation for Suicide Prevention Grant #SRG-0-133-19) 
• 2019-2024: Co-Investigator, Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes (NIH/NIDA Grant #R01DA048042) 
• 2016-2022: Principal Investigator, Pharmacoepidemiologic studies of prescription opioid analgesic risks (NIH/NIDA Grant #K99/R00DA040727) 
• 2019: Rising Star, Association for Psychological Science

Scholarly Interests

Dr. Quinn studies the causes and consequences of substance use. His interests range across substances (e.g., from cigarette smoking to opioids) and across the lifespan (e.g., from prenatal drug exposure to medication treatment for ADHD in adults). Much of his current research examines pain and its treatment with opioid medications, using longitudinal health data on individuals and families and methods from epidemiology and behavioral genetics. As a licensed psychologist, Dr. Quinn is also broadly interested in other topics in mental health.

Selected Publications

Articles

• Chen, C., Pettersson, E., Summit, A. G., Boersma, K., Chang, Z., Kuja-Halkola, R., Lichtenstein, P., & Quinn, P. D. (2023). Chronic pain conditions and risk of suicidal behavior: A 10-year longitudinal co-twin control study. BMC Medicine, 21, 9.

• Quinn, P. D., Chang, Z., Pujol, T. A., Bair, M. J., Gibbons, R. D., Kroenke, K., & D’Onofrio, B. M. (2023). Association between prescribed opioid dose and risk of motor vehicle crashes. Pain, 164, e228-e236.

• Fine, K. L., Rickert, M. E., O’Reilly, L. M., Sujan, A. C., Boersma, K., Chang, Z., Franck, J., Lichtenstein, P., Larsson, H., D’Onofrio, B. M., & Quinn, P. D. (2022). Initiation of opioid prescription and risk of suicidal behavior among youth and young adults. Pediatrics, 149, e2020049750.

• Quinn, P. D., Chang, Z., Bair, M. J., Rickert, M. E., Gibbons, R. D., Kroenke, K., & D’Onofrio, B. M. (2022). Associations of opioid prescription dose and discontinuation with risk of substance-related morbidity in long-term opioid therapy. Pain, 163, e588-e595.

• Quinn, P. D., Fine, K. L., Rickert, M. E., Sujan, A. C., Boersma, K., Chang, Z., Franck, J., Lichtenstein, P., Larsson, H., & D´Onofrio, B. M. (2020). Association of opioid prescription initiation during adolescence and young adulthood with subsequent substance-related morbidity. JAMA Pediatrics, 174, 1048-1055.

• Sujan, A. C., Quinn, P. D., Rickert, M. E., Wiggs, K. K., Lichtenstein, P., Larsson, H., Almqvist, C., Öberg, A. S., & D´Onofrio, B. M. (2019). Maternal prescribed opioid analgesic use during pregnancy and risk for adverse birth outcomes: A population-based study. PLOS Medicine, 16, e1002980.

• Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D´Onofrio, B. M. (2017). ADHD medication and substance-related problems. American Journal of Psychiatry, 174, 877-885.

• Quinn, P. D., Rickert, M. E., Weibull, C. E., Johansson, A. L. V., Lichtenstein, P., Almqvist, C., Larsson, H., Iliadou, A. N., & D´Onofrio, B. M. (2017). Association between maternal smoking during pregnancy and severe mental illness in offspring. JAMA Psychiatry, 74, 589-596.